Inactive Instrument

Company Aralez Pharmaceuticals Inc Nasdaq

Equities

CA03852X1006

Pharmaceuticals

Business Summary

Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 67,194,277 67,194,277 ( 100.00 %) 0 100.00 %

Company contact information

Old API Wind-down Ltd.

666 Burrard Street Suite 1700

V6C 2X8, Vancouver

+

address Aralez Pharmaceuticals Inc
  1. Stock Market
  2. Equities
  3. ARLZQ Stock
  4. Stock
  5. Company Aralez Pharmaceuticals Inc